Opendata, web and dolomites

NeuroTrans SIGNED

NEUROtransmitter TRANSporters: from single molecules to human pathologies

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NeuroTrans project word cloud

Explore the words cloud of the NeuroTrans project. It provides you a very rough idea of what is the project "NeuroTrans" about.

psychoactive    techniques    policy    training    structural    instruments    network    substances    transporter    industry    vision    contributes    taining    neurotrans    headed    nss    academia    pathobiology    translate    scientific    edge    function    computer    expand    simulations    predict    proteins    forming    intersectorial    solid    framework    transporters    dysfunction    commercialisation    neurotransmitter    thermodynamic    quantify    secure    team    human    oriented    cells    industrial    etn    generalizable    live    dynamics    pharmaceutical    subdisciplines    pathologies    interdisciplinary    generation    molecular    world    model    comprehending    experiments    disease    cutting    leadership    leaders    biology    sodium    principles    doctoral    innovation    single    neurobiology    technologies    biochemistry    innovative    biophysics    quantitative    mission    fundamental    kinetics    solidify    molecules    translational    neuropsychiatric    symporters    membrane    forefront    science    makers    esrs    beneficiary    classes    relevance   

Project "NeuroTrans" data sheet

The following table provides information about the project.

Coordinator
MEDIZINISCHE UNIVERSITAET WIEN 

Organization address
address: SPITALGASSE 23
city: WIEN
postcode: 1090
website: www.meduniwien.ac.at

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Austria [AT]
 Total cost 3˙994˙422 €
 EC max contribution 3˙994˙422 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2019
 Funding Scheme MSCA-ITN-ETN
 Starting year 2020
 Duration (year-month-day) from 2020-02-01   to  2024-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MEDIZINISCHE UNIVERSITAET WIEN AT (WIEN) coordinator 792˙621.00
2    KOBENHAVNS UNIVERSITET DK (KOBENHAVN) participant 595˙044.00
3    UNIVERSITY OF EAST ANGLIA UK (NORWICH) participant 303˙172.00
4    ELVESYS FR (PARIS) participant 274˙802.00
5    RIJKSUNIVERSITEIT GRONINGEN NL (GRONINGEN) participant 265˙619.00
6    UNIVERSITA DEGLI STUDI DELL'INSUBRIA IT (VARESE) participant 261˙499.00
7    LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN DE (MUENCHEN) participant 252˙788.00
8    NANION TECHNOLOGIES GMBH DE (MUNCHEN) participant 252˙788.00
9    NANOTEMPER TECHNOLOGIES GMBH DE (MUNCHEN) participant 252˙788.00
10    UNIVERSITAET HAMBURG DE (HAMBURG) participant 252˙788.00
11    UNIVERSITAET REGENSBURG DE (REGENSBURG) participant 252˙788.00
12    UNIVERSIDADE NOVA DE LISBOA PT (LISBOA) participant 237˙720.00

Map

 Project objective

The vision of the ETN network NeuroTrans (NEUROtransmitter TRANSporters: from single molecules to human pathologies) is to (i) enable an improved understanding of how dysfunction of neurotransmitter:sodium symporters (NSS) contributes to neuropsychiatric disease pathobiology and how psychoactive substances target NSS and (ii) to establish a robust framework for comprehending these pathologies through changes in transporter function at the molecular level. The mission of NeuroTrans is to develop a solid model that can predict changes in NSS function using fundamental principles obtained from quantitative experiments using an interdisciplinary approach. NeuroTrans will have a strong translational aspect through the development of enabling techniques in biophysics, molecular and structural biology and through industrial partner which establish novel instruments for use in live cells to quantify kinetics, dynamics and thermodynamic parameters, allowing for exploitation and commercialisation. The NeuroTrans research programme will have major generalizable scientific impact that will be of high relevance to academia, pharmaceutical industry and policy makers and is likely expand not only to other classes of transporters, but to membrane proteins in general. NeuroTrans will establish a highly interdisciplinary doctoral training program by forming an interdisciplinary and intersectorial team of world-leading European researchers. Training will include most important subdisciplines in quantitative biology, including molecular modelling, computer simulations, biophysics, biochemistry, neurobiology, molecular and structural biology. Taining will be headed by an industrial beneficiary to secure a strong industry oriented focus, ensuring that the ESRs can become part of Europe’s future generation of innovative leaders, be at the forefront of science and innovation, translate fundamental research into cutting-edge technologies, and solidify European industry leadership.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NEUROTRANS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NEUROTRANS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

TECHNOTRAIN (2018)

Enabling TECHNOlogies-driven chemistry: a tailored TRAINing research program for batch and flow synthesis of chiral amino derivatives

Read More  

INSPIRE (2020)

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

Read More  

REPOL (2020)

CHARACTERIZATION, COMPATIBILIZATION, PROCESSING AND PROPERTIES OF RECYCLED POLYOLEFINS

Read More